Shenzhen Bioeasy Biotechnology Co., Ltd. Share Price
Equities
300942
CNE100004C78
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.06 CNY | +1.15% | +9.46% | -39.61% |
Sales 2022 | 687M 94.85M 7.91B | Sales 2023 | 254M 35.09M 2.93B | Capitalization | 4.69B 647M 53.98B |
---|---|---|---|---|---|
Net income 2022 | 83M 11.46M 956M | Net income 2023 | -185M -25.55M -2.13B | EV / Sales 2022 | 9.55 x |
Net cash position 2022 | 310M 42.81M 3.57B | Net cash position 2023 | 236M 32.58M 2.72B | EV / Sales 2023 | 17.5 x |
P/E ratio 2022 |
81.6
x | P/E ratio 2023 |
-25.4
x | Employees | 635 |
Yield 2022 |
0.12% | Yield 2023 |
-
| Free-Float | 22.42% |
1 day | +1.15% | ||
1 week | +9.46% | ||
Current month | -19.50% | ||
1 month | -17.62% | ||
3 months | -31.59% | ||
6 months | -41.41% | ||
Current year | -39.61% |
Managers | Title | Age | Since |
---|---|---|---|
Zhao Li Xiao
CEO | Chief Executive Officer | 50 | 29/22/29 |
Kai Wan
DFI | Director of Finance/CFO | 42 | 27/21/27 |
Mei Xia Li
CHM | Chairman | 36 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Fu
BRD | Director/Board Member | 40 | 01/08/01 |
Xi Li Wang
BRD | Director/Board Member | 39 | 01/10/01 |
Mei Xia Li
CHM | Chairman | 36 | 01/12/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 7.06 | +1.15% | 4,938,211 |
25/24/25 | 6.98 | +2.65% | 4,318,400 |
24/24/24 | 6.8 | +1.19% | 3,805,265 |
23/24/23 | 6.72 | +6.33% | 6,542,223 |
22/24/22 | 6.32 | -2.02% | 5,695,954 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-39.61% | 391M | |
+1.59% | 12.8B | |
-10.29% | 7.61B | |
+3.13% | 5.41B | |
-1.16% | 4.51B | |
+7.69% | 4.49B | |
+12.21% | 2.73B | |
-15.05% | 2.02B | |
-11.50% | 1.73B | |
-0.42% | 1.64B |
- Stock Market
- Equities
- 300942 Stock